NCT02365844

Completed

Multispectral Imaging to Characterize Patterns of Vascular S...

Stanford University Source

Compare

Other study identifiers

Sponsor study identifier

ENT0044

Study Type

observational

Actual enrollment (reported)

81

Locations

1 country

Sites

1

Timeline

Study Start

February 2015

Actual (reported)

Primary Completion

August 27, 2018

Actual (reported)

Study Completion

August 27, 2018

Actual (reported)

Brief Summary

The purpose of this study is to characterize the blood supply at the base of the tongue and within the tonsil region. We hypothesize that high-resolution Narrow Band Imaging (NBI) will improve the diagnosis of oropharyngeal carcinoma (OPC). The goal is to provide the better assessment of tumor and thus providing better preoperative expectations to patients with OPC or tumor extent prior to radiation therapy.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 81 participants
Study completion date: August 27, 2018
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2015
Actual (reported)
First Submitted
February 11, 2015
Actual (reported)
First Posted
February 19, 2015
Actual (reported)
Primary Completion
August 27, 2018
Actual (reported)
Study Completion
August 27, 2018
Actual (reported)

Last Updated: March 1, 2019
Status Verified: February 2019
Last Update Submitted: February 27, 2019

Conditions

Oropharyngeal Carcinoma Oropharynx Cancer

Keywords

Narrow Band Imagingoropharyngeal carcinoma

Outcome Measures

Primary Outcomes (1)

assessment of differential vascularity between normal and clinically apparent tumor with in the specified sites of oropharynx, using standard white-light endoscopy and narrow-band imaging
endoscopy of the oropharynx using white-light and narrow-Band imaging
30 minutes

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Stanford Cancer Center patients with oropharyngeal carcinoma

You may qualify if:

age 18 years or older

Sponsors & Collaborators

Stanford University
Otherlead

Study Sites (1)

Stanford University, School of Medicine

Stanford, California, 95305, United States

MeSH Terms

Conditions

Oropharyngeal Neoplasms

Condition Hierarchy (Ancestors)

Pharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic Diseases

Study Officials

Chris Holsinger
Stanford University
PRINCIPAL INVESTIGATOR

Enrollment

81 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 11, 2015

First Posted

February 19, 2015

Study Start

February 2015

Actual (reported)

Completed

NCT05880797

Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma

Recruiting

NCT04116047

CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

Phase 3Active Not Recruiting

NCT02908477

Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

Phase 3Completed

NCT03269344

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

Phase 3Completed

NCT03049280

Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study

Not ApplicableCompleted

NCT04874493

Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer

Active Not Recruiting

Written informed consent

Patients with oropharyngeal carcinoma

You may not qualify if:

Tumors of the oral cavity or nasopharynx

Contact the study team to confirm eligibility.

Primary Completion

August 27, 2018

Actual (reported)

Study Completion

August 27, 2018

Actual (reported)

Last Updated

March 1, 2019

Record last verified: 2019-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02365844
Data provider: ClinicalTrials.gov
Source updated: 2019-03-01
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:21 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations